Comparative Study of 5 Days of M02-472 Clarithromycin Extended-Release Tablets to 7 Days of Clarithromycin Immediate-Release Tablets for the Treatment of Exacerbation of Chronic Bronchitis - Related Studies

Comparative Study of 5 Days of M02-472 Clarithromycin Extended-Release Tablets to 7 Days of Clarithromycin Immediate-Release Tablets for the Treatment of Exacerbation of Chronic Bronchitis

This study has been completed.

Study NCT00645086. Last updated on March 26, 2008. Information provided by Abbott

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Additional conditions recognized in this trial
		Bronchitis
		Bronchitis, Chronic

2	More general conditions related to this trial
		Bronchial Diseases
		Lung Diseases
		Lung Diseases, Obstructive
		Pulmonary Disease, Chronic Obstructive
		Respiratory Tract Diseases
		Respiratory Tract Infections

3	Additional drug interventions recognized in this trial
		Clarithromycin

4	More general drug interventions related to this trial
		Anti-Bacterial Agents
		Anti-Infective Agents
		Enzyme Inhibitors
		Molecular Mechanisms of Pharmacological Action
		Pharmacologic Actions
		Protein Synthesis Inhibitors
		Therapeutic Uses

5	Sponsors listed in this trial
		Abbott